Skip to main content

Table 4 The influence of individual study on the pooled estimate for outcomes

From: Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis

Outcome Study omitted HR(95%CI) I2 (%) Ph Z P value
OS Chang, 2015 [11] 1.32 (1.15–1.52) 49 0.05 3.93 <  0.01
He, 2019 [13] 1.23 (1.04–1.47) 76 <  0.01 2.38 0.02
Mouradov, 2013 [19] 1.28 (1.08–1.52) 75 <  0.01 2.83 <  0.01
Liu, 2018 [18] 1.22 (1.02–1.47) 74 <  0.01 2.18 0.03
Korphaisarn, 2017 [16] 1.23 (1.02–1.48) 75 <  0.01 2.21 0.03
Iwatsuki, 2010 [14] 1.19 (1.03–1.38) 59 0.01 2.39 0.02
Li, 2018 [17] 1.23 (1.03–1.48) 75 <  0.01 2.24 0.03
Tang, 2016 [24 1.26 (1.06–1.48) 76 <  0.01 2.69 <  0.01
Gao, 2019 [12] 1.29 (1.10–1.52) 73 <  0.01 3.10 <  0.01
Kawashita, 2017 [15] 1.24 (1.05–1.47) 76 <  0.01 2.55 0.01
DFS He, 2019 [13] 1.01 (0.56–1.80) 0 0.80 0.03 0.97
Li, 2018 [17] 1.02 (0.58–1.79) 0 0.82 0.06 0.95
Gao, 2018 [12] 1.31 (0.56–3.11) 0 0.94 0.62 0.53
Kawashita, 2017 [15] 0.99 (0.51–1.91) 0 0.78 0.03 0.98